These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 27704404

  • 1. Tablet Splitting of Antiepileptic Drugs in Pediatric Epilepsy: Potential Effect on Plasma Drug Concentrations.
    Nidanapu RP, Rajan S, Mahadevan S, Gitanjali B.
    Paediatr Drugs; 2016 Dec; 18(6):451-463. PubMed ID: 27704404
    [Abstract] [Full Text] [Related]

  • 2. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW, Varker AS, Karlage K, Myrdal PB.
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [Abstract] [Full Text] [Related]

  • 3. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
    Ciavarella AB, Khan MA, Gupta A, Faustino PJ.
    PDA J Pharm Sci Technol; 2009 Apr; 70(6):523-532. PubMed ID: 27974592
    [Abstract] [Full Text] [Related]

  • 4. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting.
    Helmy SA.
    J Manag Care Spec Pharm; 2015 Jan; 21(1):76-86. PubMed ID: 25562775
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
    Reeta KH, Mehla J, Pahuja M, Gupta YK.
    Pharmacol Biochem Behav; 2011 Sep; 99(3):399-407. PubMed ID: 21641922
    [Abstract] [Full Text] [Related]

  • 6. Is propranolol compounding from tablet safe for pediatric use? Results from an experimental test.
    Casiraghi A, Musazzi UM, Franceschini I, Berti I, Paragò V, Cardosi L, Minghetti P.
    Minerva Pediatr; 2014 Oct; 66(5):355-62. PubMed ID: 25253183
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of tablet splitting: Comparison study between hand splitting and tablet cutter.
    Habib WA, Alanizi AS, Abdelhamid MM, Alanizi FK.
    Saudi Pharm J; 2014 Nov; 22(5):454-9. PubMed ID: 25473334
    [Abstract] [Full Text] [Related]

  • 8. Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation.
    Perucca E, Dulac O, Shorvon S, Tomson T.
    CNS Drugs; 2001 Nov; 15(8):609-21. PubMed ID: 11524033
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the Discrepancy between the European Pharmacopoeia Test and an Adopted United States Pharmacopoeia Test Regarding the Weight Uniformity of Scored Tablet Halves: Is Harmonization Required?
    Zaid AN, Ghoush AA, Al-Ramahi R, Are'r M.
    PDA J Pharm Sci Technol; 2012 Nov; 66(1):20-7. PubMed ID: 22307659
    [Abstract] [Full Text] [Related]

  • 10. Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M, Albani F, Riva R, Candela C, Mohamed S, Baruzzi A.
    Ther Drug Monit; 2013 Dec; 35(6):849-52. PubMed ID: 23942540
    [Abstract] [Full Text] [Related]

  • 11. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ.
    Drugs Aging; 2003 Dec; 20(2):141-52. PubMed ID: 12534314
    [Abstract] [Full Text] [Related]

  • 12. Comparative Effect of Divided Doses of Adult Solid and Liquid Oral Formulations of Antiepileptic Drugs in the Management of Pediatric Epilepsy.
    Nidanapu RP, Tamijarassy B, Mahadevan S, Gitanjali B.
    J Pharmacol Pharmacother; 2017 Dec; 8(2):54-61. PubMed ID: 28706399
    [Abstract] [Full Text] [Related]

  • 13. Isoniazid, pyrazinamide and rifampicin content variation in split fixed-dose combination tablets.
    Pouplin T, Phuong PN, Toi PV, Nguyen Pouplin J, Farrar J.
    PLoS One; 2014 Dec; 9(7):e102047. PubMed ID: 25004128
    [Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES, Sabarinath SN, Hamdi MM, Bewernitz M, Derendorf H.
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [Abstract] [Full Text] [Related]

  • 15. Safety of antiepileptic drugs in children and young people: A prospective cohort study.
    Egunsola O, Choonara I, Sammons HM, Whitehouse WP.
    Seizure; 2018 Mar; 56():20-25. PubMed ID: 29427834
    [Abstract] [Full Text] [Related]

  • 16. Practices of tablet splitting and dose uniformity of fragments at public hospitals in Ethiopia: A cross-sectional study supported by experimental findings.
    Emagn Kasahun A, Joseph NM, Belete A.
    PLoS One; 2022 Mar; 17(12):e0279135. PubMed ID: 36520879
    [Abstract] [Full Text] [Related]

  • 17. Serum protein binding of antiepileptic drugs in Sri Lankans.
    Karunanayake EH, Joice PD, Peiris JB, Meijer JW, Meinardi H.
    Ceylon Med J; 1990 Mar; 35(1):25-8. PubMed ID: 2361227
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
    Markoula S, Teotonio R, Ratnaraj N, Duncan JS, Sander JW, Patsalos PN.
    Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
    [Abstract] [Full Text] [Related]

  • 20. Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: A step towards home sampling.
    Linder C, Wide K, Walander M, Beck O, Gustafsson LL, Pohanka A.
    Clin Biochem; 2017 May; 50(7-8):418-424. PubMed ID: 28027888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.